WHO ICTRP trial

Evaluation of the Clinical Efficacy of Antrrix probiotics in Improving Recurrent…

ChiCTR2500106317 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting

Key facts

Trial ID ChiCTR2500106317
Public title Evaluation of the Clinical Efficacy of Antrrix probiotics in Improving Recurrent Respiratory Infections in Infants and Young Children
Scientific title Evaluation of the Clinical Efficacy of Antrrix probiotics in Improving Recurrent Respiratory Infections in Infants and Young Children
Primary sponsor The Sixth Affiliated Hospital,Sun Yat-sen University Yuexi Hospital/Xinyi City People's Hospital
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Recruiting
Study type Interventional study
Countries China
Conditions Recurrent Respiratory Tract Infection
Interventions Intervention Group:In addition to conventional treatment (which may include bacterial lysates or other immunomodulatory drugs for prevention, with proven efficacy beyond acute-phase management. For RRTI cases primarily involving specific…
Registration date Jul 22, 2025
Target size Intervention Group:60;Control Group:60
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations